The discovery of the role of CARD11‐PIK3R3 in the augmentation of CBM complex signaling in a CD4 cutaneous T cell lymphoma inspired Garcia et al to elucidate how therapeutic T cells exert anti‐tumor efficacy in an antigen‐dependent manner in multiple immunotherapy‐refractory models. Here, PIK3R3 is linked to neoplasm.